1. Latest News
  2. Submit Press Release

Oncology Translational imaging for early phase anticancer drug development

Technical developments in Immuno-PET and TKI-PET and their clinical potential

March 5, 2012 - PRLog -- There is only one week remaining for SMi’s 8th annual Imaging in Cancer Drug Development conference to be held on the 14th & 15th March 2012 in London. It promises to be interactive and informative, with an increasing verity of imaging modalities available and each of them offering benefits at different stages and in different ways, there is a great deal of benefit that can be gained from their implementation.

You will hear from industry experts on the current applications of imaging in all stages of drug design, in depth verity of imaging modalities and how they can be best applied in the development process, how to use imaging techniques to reduce the long term cost of drug development and case studies discussions on how to best standardize imaging result from multi centre clinical trials

Benefits of attending

Examine the benefits of different imaging modalities and she how they can be best applied in your investigations

Review case studies on the use of imaging in multi centre clinical trials and how different teams have overcome the challenges associated with them.

Determine how upcoming EU regulations will affect the way oncology trials use of imaging will be conducted

Gain knowledge of using imaging techniques, when used, can reduce the long term cost of drug development

Communicate with industry experts on the current applications of imaging in all stages of drug design

Participate at the interactive workshop on how molecular imaging can reduce the cost of drug development

Make sure not to miss this opportunity to attend

--- End ---

Click to Share

Contact Email:
***@smi-online.co.uk Email Verified
Source:SMi Group
Location:United Kingdom
Tags:Molecular Imaging, Transaltional Imaging, Biomarkers, Cancer, Oncology, In-vivo, Pet, Mri, Ultrasound
Verified Account Email Address
Verified Account Phone Number

Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “


Trending News...

Like PRLog?
Click to Share